Literature DB >> 22542627

Lysine-specific demethylase 1 (LSD1) and histone deacetylase 1 (HDAC1) synergistically repress proinflammatory cytokines and classical complement pathway components.

Andreas Janzer1, Soyoung Lim, Florian Fronhoffs, Naima Niazy, Reinhard Buettner, Jutta Kirfel.   

Abstract

Histone modifying enzymes confer epigenetic marks, directing the changes in gene expression required for diverse cellular processes. Lysine-specific demethylase 1 (LSD1) functions as a transcriptional coregulator by demethylating histone H3 on lysine 4 and lysine 9. Analyzing transcriptomes on microarrays, we identified genes which represent inflammatory-related targets of LSD1. We demonstrate a repressive role of LSD1 in proinflammatory cytokine expression such as IL1α, IL1β, IL6 and IL8 and classical complement components. Consistently, LSD1 occupies and regulates the promoter of these genes. In addition, we demonstrate that HDAC1 and LSD1 synergistically regulate these inflammatory-related genes. Our data reveal a novel role for LSD1 in suppressing immune responses. Crown
Copyright © 2012. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22542627     DOI: 10.1016/j.bbrc.2012.04.057

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

1.  Impaired cytokine expression, neutrophil infiltration and bacterial clearance in response to urinary tract infection in diabetic mice.

Authors:  Ahmet Ozer; Cengiz Z Altuntas; Fuat Bicer; Kenan Izgi; Scott J Hultgren; Guiming Liu; Firouz Daneshgari
Journal:  Pathog Dis       Date:  2015-02-05       Impact factor: 3.166

2.  The H3K4me3 histone demethylase Fbxl10 is a regulator of chemokine expression, cellular morphology, and the metabolome of fibroblasts.

Authors:  Andreas Janzer; Katrin Stamm; Astrid Becker; Andreas Zimmer; Reinhard Buettner; Jutta Kirfel
Journal:  J Biol Chem       Date:  2012-07-23       Impact factor: 5.157

3.  Inhibition of the histone demethylase KDM4B leads to activation of KDM1A, attenuates bacterial-induced pro-inflammatory cytokine release, and reduces osteoclastogenesis.

Authors:  Joy E Kirkpatrick; Keith L Kirkwood; Patrick M Woster
Journal:  Epigenetics       Date:  2018-08-07       Impact factor: 4.528

4.  Low activity of LSD1 elicits a pro-inflammatory gene expression profile in riboflavin-deficient human T Lymphoma Jurkat cells.

Authors:  Dandan Liu; Janos Zempleni
Journal:  Genes Nutr       Date:  2014-08-08       Impact factor: 5.523

5.  Elevated expression of JMJD6 is associated with oral carcinogenesis and maintains cancer stemness properties.

Authors:  Chang-Ryul Lee; Sung Hee Lee; Nicole Kristina Rigas; Reuben H Kim; Mo K Kang; No-Hee Park; Ki-Hyuk Shin
Journal:  Carcinogenesis       Date:  2015-12-08       Impact factor: 4.944

Review 6.  Roles of lysine-specific demethylase 1 (LSD1) in homeostasis and diseases.

Authors:  Dongha Kim; Keun Il Kim; Sung Hee Baek
Journal:  J Biomed Sci       Date:  2021-06-04       Impact factor: 8.410

7.  The histone demethylase LSD1 promotes renal inflammation by mediating TLR4 signaling in hepatitis B virus-associated glomerulonephritis.

Authors:  Yi-Tong Yang; Xuan Wang; Yue-Yue Zhang; Wei-Jie Yuan
Journal:  Cell Death Dis       Date:  2019-03-20       Impact factor: 8.469

8.  Loss of LSD1 (lysine-specific demethylase 1) suppresses growth and alters gene expression of human colon cancer cells in a p53- and DNMT1(DNA methyltransferase 1)-independent manner.

Authors:  Lihua Jin; Christin L Hanigan; Yu Wu; Wei Wang; Ben Ho Park; Patrick M Woster; Robert A Casero
Journal:  Biochem J       Date:  2013-01-15       Impact factor: 3.857

9.  Tumor necrosis factor-related apoptosis-inducing ligand induces the expression of proinflammatory cytokines in macrophages and re-educates tumor-associated macrophages to an antitumor phenotype.

Authors:  Jing Gao; Dongsheng Wang; Dan Liu; Min Liu; Yehua Ge; Minghong Jiang; Yanxin Liu; Dexian Zheng
Journal:  Mol Biol Cell       Date:  2015-07-29       Impact factor: 4.138

10.  Epigenetic control and cancer: the potential of histone demethylases as therapeutic targets.

Authors:  Fernando Lizcano; Jeison Garcia
Journal:  Pharmaceuticals (Basel)       Date:  2012-09-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.